Combined CT and treatment room for acute stroke care
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial compares two ways of delivering emergency stroke treatment: one that uses a special imaging room (angio suite) where the CT scan and the clot-removal procedure are done together, versus the standard approach. The goal is to see if this combined approach speeds up treatment and improves outcomes for people with acute ischemic stroke.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 60 years old.
- You must have had an acute ischemic stroke (a blockage in a blood vessel in the brain) and be eligible for emergency endovascular treatment (a procedure to remove the clot).
- Your stroke must have started within the last 24 hours.
- You must have had a CT scan of the blood vessels in your head and neck to confirm a blockage that can be treated.
- You cannot have serious kidney disease, be on dialysis or have had a kidney transplant, and you must not be allergic to the contrast dye used in the scan.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a special emergency stroke unit that uses advanced brain imaging (NeuAngio-CT) to quickly evaluate and treat people having an acute ischemic stroke. It aims to improve outcomes by speeding up care and guiding treatment decisions.
This trial tests whether going straight to the procedure room for clot removal can speed up treatment for people having a severe stroke caused by a blocked large artery in the brain. It aims to see if this faster approach improves recovery compared to usual care.
This trial studies a way to sort and treat people with a specific type of acute ischemic stroke (caused by a blockage in a large brain artery). It may help doctors choose the best next steps—either a procedure or medication—faster and more appropriately.
This trial tests a new catheter (Super-Bore 8/7F) to remove blood clots in people having a major stroke caused by a blocked large artery in the brain. The goal is to see if it is safe and effective at restoring blood flow when used within 24 hours of stroke symptoms starting.
This trial tests if removing a large blood clot from the brain up to 3 days after a stroke improves recovery compared to standard medical care alone. It is for patients who have a severe stroke and are otherwise healthy enough for the procedure.
This trial tests whether giving a clot-dissolving medication directly into the brain's blood vessels during a standard procedure (mechanical thrombectomy) can improve outcomes for people with a stroke caused by a blockage in a medium-sized artery. It may be an option for patients who arrive at the hospital within 24 hours of symptom onset and have enough salvageable brain tissue.
Hear when a new Acute Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.